Antibodies against neuronal nicotinic receptor subtypes in neurological disorders
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 102 (1) , 89-97
- https://doi.org/10.1016/s0165-5728(99)00145-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 4‐Oxystilbene compounds are selective ligands for neuronal nicotinic αBungarotoxin receptorsBritish Journal of Pharmacology, 1998
- Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disordersCurrent Opinion in Neurobiology, 1997
- Human neuronal nicotinic receptorsProgress in Neurobiology, 1997
- Nicotinic acetylcholine receptors in health and diseaseMolecular Neurobiology, 1997
- Native Nicotinic Acetylcholine Receptors in Human Imr32 Neuroblastoma Cells: Functional, Immunological and Pharmacological PropertiesEuropean Journal of Neuroscience, 1995
- Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cellsJournal of Molecular Evolution, 1995
- Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during developmentJournal of Neuroscience, 1995
- Pharmacology and Biophysical Properties of α7 and α7 ‐ α8 α‐Bungarotoxin Receptor Subtypes Immunopurified from the Chick Optic LobeEuropean Journal of Neuroscience, 1994
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- New antigen for antibody detect ion in myasthenia gravisNeurology, 1984